CA Stock MarketDetailed Quotes
HBP Helix BioPharma Corp
- 0.770
- +0.070+10.00%
15min DelayMarket Closed Nov 22 16:00 ET
37.75MMarket Cap-733P/E (TTM)
0.770High0.750Low7.56KVolume0.750Open0.700Pre Close5.68KTurnover1.35052wk High0.02%Turnover Ratio49.02MShares0.50052wk Low-1.05EPS TTM33.91MFloat Cap40.250Historical HighLossP/E (Static)44.04MShs Float0.300Historical Low-1.05EPS LYR2.86%Amplitude--Dividend TTM-385.00P/B1Lot Size--Div YieldTTM
Helix BioPharma Corp Key Stats
Quarterly+Annual
YOY
| (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 33.79%1.08M | 33.79%1.08M | -46.62%710K | -95.75%120K | -62.68%1.64M | -75.15%808K | -75.15%808K | -29.33%1.33M | 499.58%2.82M | 134.76%4.4M |
| -Cash and cash equivalents | 33.79%1.08M | 33.79%1.08M | -46.62%710K | -95.75%120K | -62.68%1.64M | -75.15%808K | -75.15%808K | -29.33%1.33M | 499.58%2.82M | 134.76%4.4M |
| Receivables | -12.90%54K | -12.90%54K | -22.81%88K | -39.05%64K | -53.69%69K | -77.78%62K | -77.78%62K | -67.34%114K | -67.08%105K | -51.78%149K |
| -Taxes receivable | -17.02%39K | -17.02%39K | -26.26%73K | -45.56%49K | -59.70%54K | -76.85%47K | -76.85%47K | -45.60%99K | -45.12%90K | -21.64%134K |
| -Other receivables | 0.00%15K | 0.00%15K | 0.00%15K | 0.00%15K | 0.00%15K | -80.26%15K | -80.26%15K | -91.02%15K | -90.32%15K | -89.13%15K |
| Prepaid assets | 154.76%321K | 154.76%321K | 192.52%313K | -46.72%122K | -43.31%144K | -23.17%126K | -23.17%126K | 62.12%107K | 104.46%229K | 191.95%254K |
| Other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---38K |
| Total current assets | 46.18%1.46M | 46.18%1.46M | -28.37%1.11M | -90.31%306K | -61.07%1.85M | -73.04%996K | -73.04%996K | -32.48%1.55M | 250.11%3.16M | 109.87%4.76M |
| Non current assets | ||||||||||
| Net PPE | 0.00%33K | 0.00%33K | -5.56%34K | -2.56%38K | 7.89%41K | -5.71%33K | -5.71%33K | -2.70%36K | -4.88%39K | -13.64%38K |
| -Gross PPE | 0.77%1.84M | 0.77%1.84M | 0.71%1.84M | 0.71%1.84M | ---- | 0.55%1.82M | 0.55%1.82M | 0.61%1.82M | 0.61%1.82M | 0.39%1.82M |
| -Accumulated depreciation | -0.78%-1.81M | -0.78%-1.81M | -0.84%-1.8M | -0.78%-1.8M | ---- | -0.67%-1.79M | -0.67%-1.79M | -0.68%-1.79M | -0.73%-1.79M | -0.73%-1.78M |
| Other non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1K |
| Total non current assets | 0.00%33K | 0.00%33K | -5.56%34K | -2.56%38K | 5.13%41K | -5.71%33K | -5.71%33K | -2.70%36K | -4.88%39K | -11.36%39K |
| Total assets | 44.70%1.49M | 44.70%1.49M | -27.85%1.15M | -89.24%344K | -60.53%1.9M | -72.42%1.03M | -72.42%1.03M | -32.03%1.59M | 238.67%3.2M | 107.57%4.8M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 73.43%855K | 73.43%855K | 178.77%1.09M | -14.71%603K | 92.88%1.27M | -17.70%493K | -17.70%493K | -57.82%391K | -55.22%707K | -53.39%660K |
| -accounts payable | 73.43%855K | 73.43%855K | 178.77%1.09M | -14.71%603K | 92.88%1.27M | -17.70%493K | -17.70%493K | -57.82%391K | -55.22%707K | -53.39%660K |
| Current accrued expenses | 89.03%724K | 89.03%724K | 28.98%365K | ---- | ---- | 11.01%383K | 11.01%383K | -37.11%283K | -46.04%266K | 22.01%377K |
| Other current liabilities | ---- | ---- | --50K | ---- | ---- | --998K | --998K | ---- | ---- | --4.63M |
| Current liabilities | -15.74%1.58M | -15.74%1.58M | 123.29%1.51M | -38.03%603K | -77.53%1.27M | -45.08%1.87M | -45.08%1.87M | -79.65%674K | -75.75%973K | 50.61%5.67M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -15.74%1.58M | -15.74%1.58M | 123.29%1.51M | -38.03%603K | -77.53%1.27M | -45.08%1.87M | -45.08%1.87M | -84.17%674K | -80.68%973K | 12.35%5.67M |
| Shareholders'equity | ||||||||||
| Share capital | 4.28%158.57M | 4.28%158.57M | 2.90%156.48M | 1.77%154.75M | 4.62%154.75M | 3.09%152.07M | 3.09%152.07M | 5.66%152.07M | 8.25%152.07M | 5.60%147.92M |
| -common stock | 4.28%158.57M | 4.28%158.57M | 2.90%156.48M | 1.77%154.75M | 4.62%154.75M | 3.09%152.07M | 3.09%152.07M | 5.66%152.07M | 8.25%152.07M | 5.60%147.92M |
| Additional paid-in capital | 7.30%47.36M | 7.30%47.36M | 11.41%46.56M | 14.70%46.07M | 16.20%44.81M | 17.42%44.14M | 17.42%44.14M | 39.32%41.79M | 44.11%40.16M | 38.38%38.56M |
| Retained earnings | -4.60%-210.67M | -4.60%-210.67M | -3.08%-205.39M | -2.86%-203.56M | -3.02%-202.66M | -3.22%-201.41M | -3.22%-201.41M | -2.85%-199.25M | -2.87%-197.91M | -3.34%-196.72M |
| Other equity interest | 6.70%4.65M | 6.70%4.65M | -68.31%2M | -68.56%2.49M | -60.35%3.72M | -57.84%4.36M | -57.84%4.36M | -64.73%6.31M | -60.37%7.9M | -52.39%9.38M |
| Total stockholders'equity | 89.35%-90K | 89.35%-90K | -139.43%-360K | -111.65%-259K | 171.91%622K | -364.89%-845K | -364.89%-845K | 147.45%913K | 154.35%2.22M | 68.32%-865K |
| Total equity | 89.35%-90K | 89.35%-90K | -139.43%-360K | -111.65%-259K | 171.91%622K | -364.89%-845K | -364.89%-845K | 147.45%913K | 154.35%2.22M | 68.32%-865K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data